Navigation Links
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014
Date:7/28/2014

SEATTLE, July 28, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its second quarter 2014 financial results on Monday, August 4, 2014, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general corporate update at 4:30 p.m. EDT (1:30 p.m. PDT). Access to the event can be obtained as follows:

Monday, August 4
1:30 p.m. PDT/4:30 p.m. EDT/10:30 p.m. CEST
1-888-461- 2024 (domestic) 
+1 719-325-2464 (international)

To access the live audio webcast or the subsequent archived recording, visit CTI's website, www.ctibiopharma.com. Webcast and telephone replays of the conference call will be available at approximately two hours after completion of the call. Callers can access the replay by dialing 1-888-203-1112 (domestic) or +1 719-457-0820 (international). The access code for the replay is #1937280. The telephone replay will be available until Monday, August 11, 2014.

About CTI BioPharma

CTI BioPharma Corp. (NASDAQ and MTA: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. CTI has a commercial presence in Europe and a late-stage development pipeline, including pacritinib, CTI's lead product candidate that is currently being studied in a Phase 3 program for the treatment of patients with myelofibrosis. CTI is headquartered in Seattle, Washington, with offices in London and Milan under the name CTI Life Sciences Limited. For additional information and to sign up for email alerts and get RSS feeds, please visit www.ctibiopharma.com.

Contacts: 
Monique Greer
+1 206-272-4343
mgreer@ctibiopharma.com  

Ed Bell
+1 206-282-7100
ebell@ctibiopharma.com  

In Europe:  CTI Life Sciences Limited, Milan Branch
Laura Villa 
+39 02 94751572
lvilla@cti-lifesciences.com


'/>"/>
SOURCE CTI BioPharma Corp.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... SAN FRANCISCO , March 1, 2017 The global  ... based on a new report by Grand View Research, Inc. The intraoperative neuromonitoring ... be attributed to the hospitals adopting intraoperative monitoring in a wide spectrum of ... ... Grand View Research Logo ...
(Date:3/1/2017)... , Italia, March 1, 2017 El mismo sistema se mostrará ... Continue Reading ... The open MRI scanner - MROpen ... ... MROpen en el Reino Unido y la primera en Gales. El escáner se localizará en ...
(Date:2/28/2017)... , Feb. 28, 2017 Mechanical Ventilators ... full report: https://www.reportbuyer.com/product/4402626/ This report ... on the global and regional levels. It provides historical ... 2024 in terms of revenue (US$ Mn) and volume ... an outlook on mechanical ventilators sales globally. It includes ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... March 01, 2017 , ... Cognition Corporation ... a Human Factors Engineering (HFE) keynote speaker for its 2017 User Conference. , ... Cognition. “Human Factors is a dynamic part of product development, and our speaker ...
(Date:3/1/2017)... IL (PRWEB) , ... March 01, 2017 , ... First ... its latest funding round of $1.6 million. First Stop Health has raised total capital ... accelerate the company’s growth. , First Stop Health co-founder and CEO Patrick Spain (co-founder ...
(Date:3/1/2017)... ... March 01, 2017 , ... One of the most popular shows on ... the beloved character Toby being shocked back to life after suffering cardiac arrest on ... quickly back to his old self, ready to marry his best girl. In ...
(Date:3/1/2017)... (PRWEB) , ... March 01, 2017 , ... ... the treatment of eating disorders, is pleased to announce the opening of residential ... facility. Starting this week, Aloria Health will accept adult clients for residential treatment. ...
(Date:3/1/2017)... , ... March 01, 2017 , ... ... Lung Cancer Conference® on April 8, 2017, in Sunny Isles Beach, Florida. The ... officer, Massachusetts General Physicians Organization, Boston, and Dr. Heather Wakelee, associate professor of ...
Breaking Medicine News(10 mins):